Serial Measurement of Interleukin-6 Enhances Chance to Exclude Early-Onset Sepsis in Very Preterm Infants

Clin Pediatr (Phila). 2023 May;62(4):288-294. doi: 10.1177/00099228221124672. Epub 2022 Sep 22.

Abstract

The aim of this retrospective study was to evaluate the reliability of peak interleukin-6 (IL-6) level within 24 hours after delivery as a predictor for early-onset sepsis (EOS) in very preterm neonates. Interleukin-6 was assessed at 2 hours and at 12 to 24 hours after delivery. The highest level was considered a peak value. The definition of EOS was based on positive blood culture and clinical signs of infection or negative blood culture, clinical signs of infection, and C-reactive protein >10 mg/L. Among 445 enrolled infants, 53 developed EOS. A peak IL-6 level of more than 200 ng/L had a sensitivity of 89% and specificity of 77% for the presence of EOS. The negative predictive value was 98%. Receiver operating characteristics curve had area under the curve of 0.92. Peak IL-6 is a reliable marker of systemic inflammatory response and might be useful to exclude EOS within the first 24 hours.

Keywords: interleukin-6; neonatal early-onset sepsis; systemic inflammatory response; very preterm infants.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • C-Reactive Protein / analysis
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Infant, Premature, Diseases*
  • Interleukin-6
  • Neonatal Sepsis* / diagnosis
  • Reproducibility of Results
  • Retrospective Studies
  • Sepsis* / diagnosis

Substances

  • Interleukin-6
  • C-Reactive Protein
  • Biomarkers